Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
06/2010
06/02/2010CN101716173A Anemonin and application of composition thereof to anti-virus aspect
06/02/2010CN101716161A New thymosin chitosan microsphere type oral medicinal preparation and preparation method thereof
06/02/2010CN101716159A Stable lansoprazole tablet and preparation method thereof
06/02/2010CN101716158A Method for preparing matrine slow-release tablet by applying attapulgite
06/02/2010CN101716154A Ursolic acid oral dispersant and preparation method thereof
06/02/2010CN101716146A Vancomycin slow release microsphere with magnetic filed compliance and preparation method thereof
06/02/2010CN101716137A Entecavir injection
06/02/2010CN101716136A Famotidine injection and preparation method thereof
06/02/2010CN101715910A Composition of banana oligosaccharide and dietary fibre, preparation method and application thereof
06/02/2010CN101480408B Nutrient health-care liquid for coloclysis
06/02/2010CN101366946B Starch based segmented intestine targeting specific adhesion material, preparation and application thereof
06/02/2010CN101305975B Health preservation feet bath bag
06/02/2010CN101249266B Nano liver target direction amphipathic nature block copolymers drug administration system and preparation
06/02/2010CN101244057B 3-substituted oxygen group-3',4'-dimethoxy flavonoid compound with blood fat reducing function
06/02/2010CN101214368B Medicament for treating nausea emesis caused by radiotherapy and chemotherapy
06/02/2010CN101204514B Chinese traditional medicine composite for gastric ulcer
06/02/2010CN101204512B Preparing method of nourishing and health-caring wine
06/02/2010CN101204494B Medicine for chronic enteritis
06/02/2010CN101199818B Medicament compound for treating calculus
06/02/2010CN101199563B Use of Loosestrife total saponine in preparing medicine for treating liver cancer
06/02/2010CN101199540B Polygonin sheet and preparing method thereof
06/02/2010CN101199510B Silybin precursor multiphase lipidosome formulation and preparing method thereof
06/02/2010CN101185717B Traditional Chinese medicine for treating acute chronic gastroenteritis and intestine gastric ulcer
06/02/2010CN101181595B Chinese medicine composition orally taken for curing superficial gastritis
06/02/2010CN101181419B Chinese medicine composition for curing simple periodontitis
06/02/2010CN101156910B A dysentery stopping traditional Chinese medicine preparation for animals and method for making same
06/02/2010CN101152530B Method for preparing defervesce and promoting digestion capsule for children
06/02/2010CN101152197B Compound glycyrrhizin dropping pills and method for preparing the same
06/02/2010CN101099845B Medicine for treating stomach disease and its preparation method
06/02/2010CN101077113B Se-enriched cordyceps militaris tea and its preparing process
06/02/2010CN101066298B Chinese medicine powder for treating portacaval mucositis
06/02/2010CN101053594B Traditional Chinese medicinal composition for treating lithiasis and its preparation method
06/02/2010CN101040914B Chinese traditional medicine compound for treating insafficiencg of kidney-yang and hypogastric blood stasis and its preparation method
06/02/2010CN101002786B Plaster for treating hepatitis B, and its preparing method
06/02/2010CA2646359A1 A carious-bacteria-kill nano-toothpaste
06/01/2010US7728109 Antagonistic anti-hTNFSF13b human antibodies
06/01/2010US7728006 Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
06/01/2010US7728005 such as N-(2-bromophenyl)-N'-[2-(4-fluorophenoxy)ethyl]urea, having superior antiinflammatory and analgesic activity
06/01/2010US7727999 substituted 1,3,8-triaza-spiro[4.5]decan-2-one compounds, used as selective serotonin receptor antagonists, used rfor the treatment of schizophrenia, psychosis, headaches, hypertension, thrombosis, vasospasm, depression, anxiety, sleep disorders and appetite disorders
06/01/2010US7727998 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient
06/01/2010US7727992 2-(3-Ethyl-ureido)-6-pyridin-3-yl-3H-benzoimidazole-4-carboxylic acid methyl ester; for treating bacterial infections in mammals; useful in treating or lessening severity of urinary tract infections, pneumonia, prostatitis, skin and soft tissue infections, intra-abdominal infections
06/01/2010US7727980 Tricyclic androgen receptor modulator compounds and methods
06/01/2010US7727712 Having an immunostimulatory sequence comprising the sequence 5'-C, G-3', wherein an HBV antigen is not administered in conjunction with administration of said nucleotide; for treatment of subject with hepatitis B virus
06/01/2010US7727519 Method for treating hepatitis C virus with omega interferon
06/01/2010CA2525867C Natural compounds and their derivatives for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications
06/01/2010CA2440699C Compounds for treating inflammatory diseases
06/01/2010CA2440680C Steroids as agonists for fxr
06/01/2010CA2423007C Spiro derivatives and adhesion molecule inhibitors containing the same as effective ingredients
06/01/2010CA2409827C Arylmethylamine derivatives for use as tryptase inhibitors
06/01/2010CA2366750C (e)-styryl sulfone anticancer agents
06/01/2010CA2352524C Aromatic heterocyclic compounds as antiinflammatory agents
05/2010
05/27/2010WO2010060070A2 Indolinone modulators of dopamine receptor
05/27/2010WO2010059853A1 Tgr5 modulators and method of use thereof
05/27/2010WO2010059245A2 Compositions and methods for treating or preventing radiation injury
05/27/2010WO2010058858A1 Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
05/27/2010WO2010058846A1 4,6-diaminonicotinamide compound
05/27/2010WO2010058795A1 Antioxidant
05/27/2010WO2010058794A1 Antioxidant
05/27/2010WO2010058550A1 Therapeutic or prophylactic agent for liver diseases comprising anti-human ggt antibody
05/27/2010WO2010058517A1 NERVE CELL STIMULATOR COMPRISING IgG AND/OR Fc FRAGMENT OF IgG
05/27/2010WO2010057443A1 Use of 9,10-anthraquinone compounds
05/27/2010WO2010057260A1 Method for treating or preventing a pancreatic dysfunction
05/27/2010WO2010038155A3 Antibodies against il-25
05/27/2010WO2010017403A3 Therapeutic compositions, devices and methods for observing treated tissues
05/27/2010WO2010011347A3 Clip inhibitors and methods of modulating immune function
05/27/2010WO2008070780A9 Antagonist antibodies against ephb3
05/27/2010US20100130588 Novel lipid formulations for nucleic acid delivery
05/27/2010US20100130547 Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide
05/27/2010US20100130512 Fused-ring heterocycle opioids
05/27/2010US20100130504 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
05/27/2010US20100130491 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7 ) modulators
05/27/2010US20100130483 Novel diazabicyclic aryl derivatives
05/27/2010US20100130481 Anticonvulsant and anxiolytic methods of using receptor subtype selective agents
05/27/2010US20100130475 administering 7,8-dimethoxy-4(5H),10-dioxo-1H-1,2,3-triazolo[4,5-c][1]benzoazepine, a prodrug 2-(1-isopropoxycarbonyloxy-2-methylpropyl)-7,8-dimethoxy-4(5H),10-dioxo-2H-1,2,3-triazolo[4,5-c][1]benzoazepine for the treament of Crohn's disease
05/27/2010US20100130472 Bile acid recycling inhibitors for treatment of obesity and diabetes
05/27/2010US20100130467 Triazolotriazines as kinase inhibitors
05/27/2010US20100130441 Use of vitamin b12 for treatment of mucosal lesions
05/27/2010US20100130408 Use of modified cyclosporins
05/27/2010US20100129476 Composition comprising rehmanniae radix preparata, notoginseng radix or mixture extract thereof for preventing and treating of periodontitis as an effective component
05/27/2010US20100129462 Decolonizing agent for helicobacter pylori
05/27/2010US20100129442 Oral Multi-Functional Pharmaceutical Capsule Preparations Of Proton Pump Inhibitors
05/27/2010US20100129351 Compositions and Methods for Altering Pancreas or Liver Function
05/27/2010US20100129345 Screening method for prokinetic agent
05/27/2010US20100129337 Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
05/27/2010US20100129335 Reduction of risk diarrhoea
05/27/2010US20100129322 Tetracycline-sensitive bifidobacteria strains
05/27/2010US20100129298 Recalcification Promoter And Composition For Oral Cavity
05/27/2010US20100129296 Extract of trigonella foenum-graecum
05/27/2010CA2744388A1 Compositions and methods for treating or preventing radiation injury
05/27/2010CA2744228A1 Method for treating or preventing a pancreatic dysfunction
05/27/2010CA2744189A1 Tgr5 modulators and methods of use thereof
05/27/2010CA2743172A1 Crystalline form of linaclotide
05/27/2010CA2742947A1 Antioxidant
05/27/2010CA2742946A1 Antioxidant
05/27/2010CA2741511A1 Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
05/26/2010EP2189521A1 Lactic acid bacteria and their cellular components inducing immunoregulatory function, and method of obtaining the same
05/26/2010EP2189475A2 Fibroblast growth factor-like polypeptides
05/26/2010EP2189451A1 Benzamide derivatives, their preparation and uses in medicine thereof
05/26/2010EP2189156A1 Lys-Pro and Lys-Pro-Thr for the manufacture of a cosmetic composition
05/26/2010EP2188263A1 Benzimidazole derivatives used as fxr agonists
1 ... 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 ... 1258